[#item_full_content]Allspring Global Investments is pushing clients toward countries with central banks that are raising interest rates…
Author: Mb
SpaceX to join the Nasdaq-100 in a fast-tracked process that will drive huge ETF buying demand
[#item_full_content]Adding SpaceX this quickly would make the Elon Musk company one of the first beneficiaries of…
Jeremy Grantham says, ‘This is the most expensive market in American history’
[#item_full_content]Jeremy Grantham says soaring valuations around AI makes the U.S. stock market historically expensive.
SpaceX will join Nasdaq-100
[#item_full_content]Adding SpaceX this quickly would make the Elon Musk company one of the first beneficiaries of…
GameStop Provides Fiscal Year 2026 Outlook
[#item_full_content]
Thubrikar Aortic Valve partners with MAC’s MEDICAL Group and expands the TAVI-1 CE Mark trial of the Optimum TAVI System™
[#item_full_content]COLLEGEVILLE, Pa.–(BUSINESS WIRE)– #TAVI–Thubrikar Aortic Valve, Inc. today announced its partnership with MAC’s MEDICAL Group, a…
CFTC is conducting an investigation into Polymarket, source says
[#item_full_content]The probe comes after the Commodity Futures Trading Commission and the Department of Justice dropped previous…
OpenAI is reportedly delaying its IPO. Here’s when Kalshi traders think it will announce
[#item_full_content]Speculators think the OpenAI IPO will come early next year, with only one-in-three odds it happens…
Warsh reaches within the Fed for latest advisory appointments
[#item_full_content]Warsh has added two more key advisors as he seeks to remake how the central bank…
Minneapolis Fed President Neel Kashkari says he expects a rate hike this year
[#item_full_content]Kashkari said he sees a hike likely this year as the economy continues to feel the…
Minneapolis Fed President Neel Kashkari says he expects a rate hike this year
[#item_full_content]Kashkari said he sees a hike likely this year as the economy continues to feel the…
Riassunto: LabGenius Therapeutics e LG Chem stringono un accordo di collaborazione nella ricerca, di opzione e di licenza per sviluppare un anticorpo monoclonale progettato con AI/ML
[#item_full_content]LONDRA–(BUSINESS WIRE)–LabGenius Therapeutics (“LabGenius”), azienda di scoperta farmacologica che combina l’apprendimento automatico (ML) con la sperimentazione…
Riassunto: LabGenius Therapeutics e LG Chem stringono un accordo di collaborazione nella ricerca, di opzione e di licenza per sviluppare un anticorpo monoclonale progettato con AI/ML
[#item_full_content]LONDRA–(BUSINESS WIRE)–LabGenius Therapeutics (“LabGenius”), azienda di scoperta farmacologica che combina l’apprendimento automatico (ML) con la sperimentazione…
Samenvatting: LabGenius Therapeutics en LG Chem sluiten een samenwerkingsovereenkomst voor onderzoek, inclusief optie en licentie, voor de ontwikkeling van een door AI/ML ontworpen tumorgerichte antistof
[#item_full_content]LONDEN–(BUSINESS WIRE)–LabGenius Therapeutics (‘LabGenius’), een bedrijf voor geneesmiddelenontwikkeling dat machine learning (ML) en experimentatie met hoge…
Samenvatting: LabGenius Therapeutics en LG Chem sluiten een samenwerkingsovereenkomst voor onderzoek, inclusief optie en licentie, voor de ontwikkeling van een door AI/ML ontworpen tumorgerichte antistof
[#item_full_content]LONDEN–(BUSINESS WIRE)–LabGenius Therapeutics (‘LabGenius’), een bedrijf voor geneesmiddelenontwikkeling dat machine learning (ML) en experimentatie met hoge…
Resumen: LabGenius Therapeutics y LG Chem suscriben un acuerdo de colaboración en investigación, opción y licencia para desarrollar un anticuerpo dirigido a tumores de diseño asistido por IA/aprendizaje automático
[#item_full_content]LONDRES–(BUSINESS WIRE)–LabGenius Therapeutics (“LabGenius”), una empresa de descubrimiento de fármacos que combina aprendizaje automático y experimentación…
LabGenius Therapeutics et LG Chem concluent un Contrat de collaboration de recherche assorti d’une option de licence pour développer un anticorps ciblant les tumeurs conçu par l’IA et le ML
[#item_full_content]LONDRES–(BUSINESS WIRE)–LabGenius Therapeutics (« LabGenius »), société de découverte de médicaments qui combine l’apprentissage machine (ML) et l’expérimentation…